ADME and Toxicology 2013

Welcome to ADME and Toxicology 2013 conference and exhibition. 

ADME and Toxicology testing has become one of the most important research activities related to new drug discovery. Ensuring that the drugs make it to the market quicker with higher hit rates thereby saving cost, requires prior indication of human toxicity as well as pharmacokinetics and therefore is of utmost importance. Since the pharmaceutical and biotechnology companies are utilizing the newer technologies, ADME and toxicology screening at early stages of drug discovery and development process has become even more imperative.
 
Our ADME & Toxicology 2013 is an international event being hosted in New Delhi, India. This event will focus on the vital role of ADME and Toxicology in identification and design of a successful drug candidate. Our array of Keynote Speakers will give presentations on all areas of ADME and Toxicology backed up by a panel of expert speakers speaking on highly relevant and “hot” topics such as Pharmacogenomics and Drug Safety, In-silico PK/PD, Toxicity and Genotoxicity Modeling, New Therapeutic Targets, Metabolomics and ADME Optimization for Drug Design/Discovery.
 
Also, co-located with our ADME & Toxicology 2013 conference will be our Nanomedicine meeting. Registered delegates will have unrestricted access to both meetings ensuring a comprehensive learning and sharing experience as well as being financially beneficial for attendees.

Keynote Speakers

Bhupinder Bhoop Professor, Panjab University

Yogender Gupta Professor, All India Institute of Medical Sciences

Jyoti Paliwal Medical Advisor, Troikaa Pharmaceuticals Limited

Matthew Segall CEO, Optibrium Ltd